Linear Clinical Research Menu
Paid Clinical Trials Patient Trials Cancer Trials

Clinical Trial Participants


The Privacy Act 1988 (Privacy Act) requires entities bound by the Australian Privacy Principles to have a privacy policy.

This privacy policy outlines the personal information handling practices at Linear Clinical Research Limited (Linear) as they pertain to current or potential clinical trial patients/participants (“you”). This policy explains:

  • what types of personal information we might collect;
  • how we aim to use personal information;
  • when we will disclose personal information to others;
  • how you can access personal information that we hold about you; and
  • how we manage and secure personal information.

Linear is a specialist clinical trial organisation, operating out of purpose-built, state-of-the-art facilities within Western Australia. Linear has the Australian advantage of fast regulatory approval time to achieve first-in-human clinical data and extensive experience in adaptive healthy volunteer / patient protocol designs.

Linear provides international biopharmaceutical companies access to Australia’s brightest minds and talented clinical research professionals for innovative medicines. Research and the clinical trial is a fundamental tool of modern medicine – the clinical trial is the medical invention that has contributed
to nearly all of the lifesaving medicines that we know today. Linear’s rapid and quality-driven services secure innovative, world-class clinical research trials to ultimately improve patient health outcomes world-wide.

We have an existing unique collaboration with a 600-bed tertiary teaching hospital (Sir Charles Gairdner Hospital, SCGH) and the State Health Department, to perform healthy volunteer studies and recruit different patient populations from anywhere in the State into early phase clinical research. This connection also enables us to work with specialised physicians for a variety of therapeutic areas. Linear also operates a dedicated clinical trials clinic in Joondalup.

Linear collects, holds, uses and discloses personal information to carry out these functions or activities.


In this privacy policy, personal information and sensitive information (a sub-set of personal
information), have the same meanings as defined in subsection 6(1) of the Privacy Act, namely:
Personal information means information or an opinion about an identified individual, or an individual
who is reasonably identifiable:

  • whether the information or opinion is true or not; and
  • whether the information or opinion is recorded in a material form or not.
    Sensitive information means:
  • information or an opinion about an individual’s:
    • racial or ethnic origin;
    • political opinions;
    • membership of a political association;
    • religious beliefs or affiliations;
    • philosophical beliefs;
    • membership of a professional or trade association;
    • membership of a trade union;
    • sexual orientation or practices; or
    • criminal record,
      that is also personal information;
  • health information about an individual;
  • genetic information about an individual that is not otherwise health information;
  • biometric information that is to be used for the purpose of automated biometric
    verification or biometric identification; or
  • biometric templates.
Health information means:
  • information or an opinion about:
    • the health, including an illness, disability or injury, (at any time) of an individual; or
    • an individual’s expressed wishes about the future provision of health services to the
      individual; or
    • a health service provided, or to be provided, to an individual;
that is also personal information;
  • other personal information collected to provide, or in providing, a health service to an
  • other personal information collected in connection with the donation, or intended
    donation, by an individual of his or her body parts, organs or body substances;
  • genetic information about an individual in a form that is, or could be, predictive of the
    health of the individual or a genetic relative of the individual.

De-identified information means personal information that is no longer about an identifiable
individual or an individual who is reasonably identifiable.


  • As a patient/participant or prospective patient/participant in a clinical trial, the collection of
    personal and sensitive information is a necessary part of ensuring that:

    • the patient/participant’s safety is paramount;
    • we are able to communicate with you in a timely manner;
    • we are able to provide you with information about clinical trials;
    • only suitable patients/participants are included in clinical trials;
    • a diverse population of patients/participants is enrolled into a clinical trial (where the
      clinical trial protocol allows for such diversity); and
    • we comply with our legal obligations.
  • As a patient/participant or prospective patient/participant in a clinical trial, the information thatmay be collected from you may include, but is not limited to:
    • name;
    • title;
    • date of birth;
    • sex/gender;
    • address and other contact details, including email address and telephone numbers;
    • driver’s licence number and expiry date;
    • tax file number;
    • bank account details;
    • current employment and employment history;
    • employment conditions;
    • physical or mental health;
    • disability status;
    • racial or ethnic origin, cultural background or culturally sensitive issues;
    • Medicare card number;
    • details related to health status – past and present;
    • details related to lifestyle factors such as smoking status, use of drugs (prescribed, over-the-counter and illicit), consumption of alcohol; and
    • details related to body height, weight and other physiological measurements (e.g. heart rate, blood pressure, etc).
  • Linear may also collect information about you from publicly available sources. Note that information (which would otherwise be considered personal) is, if in the public domain, no longer considered personal information according to the Privacy Act.
  • Information may be collected by means such as via telephone, on electronic forms or questionnaires, and on hard-copy forms upon visiting Linear.
    • By engaging in a phone call with Linear Clinical Research, you consent to the recording of the call. Recorded calls are used for internal purposes, such as training our staff, ensuring quality service delivery, and complying with applicable laws and regulations.
    • You will be notified at the beginning of the call that your call may be recorded. If you do not consent to the recording, please disclose this request to our staff member. 
    • Recorded call data is stored securely and will be retained for 6 months to fulfil the purposes outlined in this policy. After this period, recorded call data will be securely deleted.
  • We will also collect health information from clinical trial patients/participants. This health information is sensitive information and will be subject to greater regulation under the Australian Privacy Principles.
  • If Linear receives additional, unsolicited personal information that was not explicitly requested, the same standards will be applied as other personal information collected by Linear, in accordance with the provisions of Linear’s privacy policy.
  • Personal information that has been de-identified is no longer considered to be personal information.


We aim to keep all personal information up-to-date and accurate and so we encourage you to let us know of any changes in your personal information, including your contact details.


  • Access to Linear records and disclosure of your personal information is limited to those who have an operational need or who have legislative authority. These include but are not limited to:
    • Linear Chief Executive Officer (CEO) and staff;
    • Suppliers to Linear, where the personal information is required for providing the service (e.g. pathology, radiology, treating hospital);
    • Monitors and auditors appointed by sponsors, certifying authorities or ethics committees;
    • the Commonwealth Ombudsman;
    • the Office of the Australian Information Commissioner;
    • Administering Institutions;
    • the Australian Taxation Office; and
    • the Australian Federal Police.
  • Linear will not be taken to have breached its obligations under this policy or the Privacy Act where:
    • a person has consented to the use or disclosure of their personal information;
    • a purpose for which the personal information is to be used is directly related to the purpose for which it was collected;
    • a person would reasonably expect, or has been told, that personal information may be published or passed to certain individuals, bodies or agencies (e.g. if requested by the Australian Taxation Office);
    • the disclosure of personal information:
      • is required or permitted by law; or
      • will prevent or lessen a serious and imminent threat to somebody’s life or health;
    • there is a reasonable belief that the disclosure of the personal information is for a purpose directly related to the enforcement or investigation of a possible breach of a Commonwealth, State or Territory law; or
    • the personal information is in the public domain.


You have specific rights under Australian Law to request access to and correction of personal
information that Linear holds about you.

  • You can request access to the personal information that Linear holds about you subject to certain exceptions under the Privacy Act. You are also entitled to specify how you wish to access
    your personal information, so long as this is reasonable and practicable. In order to access your
    personal information please discuss this with the Linear Chief Executive Officer (CEO); requests
    can be made via routes in the “Contact Us” section below.
  • Given that the information will have been of a sensitive nature, we will need to verify the identity
    of anyone requesting access to your personal information, so as to ensure that we do not provide
    that information to a person or people who do not have the right to access that information. In
    furtherance of this objective, we ask that any requests for information be as specific as possible
    so that we can accommodate your request. We will usually provide you with access within thirty
    (30) days of a request but in some circumstances it may take longer.
  • Please note that under Australian law, Linear is entitled to refuse you access to your information
    in the following circumstances:

    • where access would be unlawful;
    • denying access is required or authorised by or under an Australian law or a Court / Tribunal order; or
    • access would prejudice enforcement activities or the taking of appropriate action in relation to unlawful activity or serious misconduct.
  • Linear takes every step that is reasonably practicable to ensure that the personal information we collect, use and disclose is accurate, complete and up-to-date. To facilitate this, please let us know if any of your details change or in the event you wish your personal information to be removed from our database as the Privacy Act gives you the right to request correction or removal of the personal information we hold or if that personal information is incorrect. In order to do so, please contact Linear via our email at or Telephone: +61 (08) 6382 5100.
  • In the event we do not agree to your request for correction or removal, we will give you notice of this outlining our reasons and what next steps you can take. You may also request us to associate a statement with that information to the effect that the information is inaccurate, out of date, incomplete, irrelevant or misleading so that it is apparent to any users of the information.
  • If you consent to take part in a study, Linear is required by clinical trial regulations to maintain your personal information that is part of study records for a minimum 15 years, during which time your information cannot be removed.


Under no circumstances will Linear sell or receive payment for licensing or disclosing your
personal information.


  • Linear takes steps to protect the security of the personal information it holds electronically from
    both internal and external threats by:

    • holding this information on secure servers in controlled facilities;
    • regularly assessing the risk of misuse, interference, loss, and unauthorised access,
      modification or disclosure of that information;
    • taking measures to address those risks, for example, keeping a record (audit trail) of when
      someone has added, changed or deleted personal information held in our electronic
      databases and regularly check that staff only access those records when they need to;
    • conducting regular internal and external audits to assess whether Linear has adequately
      complied with or implemented these measures.
  • Some information is collected and held in hard-copy, which is retained in secure facilities.
  • For further information on the way Linear manages security risks in relation to personal information please contact us via email at


  • If you have a complaint about our Privacy Policy or the collection, use or safe disposal or destruction of personal information, a complaint should be directed in the first instance to the Chief Executive Officer of Linear Clinical Research Limited.
  • We will investigate the complaint and attempt to resolve any breach that might have occurred in
    relation to the collection, use or destruction of personal information held by us in accordance
    with the Commonwealth Privacy legislation.
  • If you are not satisfied with the outcome of this procedure then you may request that an
    independent person (usually the Commonwealth Privacy Officer) investigate your complaint.


Pursuant to the Privacy Act 1988 we may transfer personal information we have collected about an individual to someone other than that individual in a foreign country only if such transfer is permitted by the Privacy Act. The likely countries that information may be sent to include the USA, the European Union, China and Japan. Any such transfer would be done when required for a specific trial (e.g. to an international sponsor). You will be informed of international transfers, prior to them taking place, within the trial-specific informed consent form.


If you have any queries, concerns or complaints about this privacy policy or the way in which we handle your personal information, or if you would like to make any recommendations or comments to improve the quality of our Privacy Policy, please contact us via email on or Tel: +61 (08) 6382 5100 or visit our website at